Cargando…

Bortezomib-Based Regimens and Plasma Cell Leukemia

Detalles Bibliográficos
Autor principal:	Bolaman, Ali Zahit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2021
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927453/ https://www.ncbi.nlm.nih.gov/pubmed/33463973 http://dx.doi.org/10.4274/tjh.galenos.2021.2020.0679

Ejemplares similares

Leukemia and rosiglitazone
por: Yavasoglu, Irfan, et al.
Publicado: (2016)

Auer Rods Are Not Seen in Non-Neoplastic Cells
por: Yavaşoğlu, İrfan, et al.
Publicado: (2016)

Penile Ulcer Atra Related in Patient with Acute Promyelocytic Leukemia
por: Yavasoglu, Irfan, et al.
Publicado: (2012)

Sweet Syndrome Associated with Ixazomib
por: Yavaşoğlu, İrfan, et al.
Publicado: (2021)

Masquerading of COVID-19 Infection as Primary Mediastinal Large B-Cell Lymphoma
por: Bolaman, Ali Zahit, et al.
Publicado: (2021)

Multiple Myeloma and Alkaline Phosphatase
por: Yavaşoğlu, İrfan, et al.
Publicado: (2015)

Eyebrow Whitening Induced by Imatinib
por: Yavasoglu, Irfan, et al.
Publicado: (2020)

Chlorella-induced thrombocytopenia
por: Yavasoglu, Irfan, et al.
Publicado: (2018)

Rheumatoid Arthritis and Anti-Thyroid Antibodies
por: Yavasoglu, Irfan, et al.
Publicado: (2009)

Bone and Bone Marrow Involvement in Sarcoidosis
por: Sargın, Gökhan, et al.
Publicado: (2014)

Cabot ring-like faggot cells in acute promyelocytic leukemia
por: Yavasoglu, Irfan, et al.
Publicado: (2022)

Relationship between bortezomib-containing regimens and the incidence of tuberculosis in patients with myeloma
por: Kim, Kihyun, et al.
Publicado: (2013)

Successful treatment with bortezomib-containing regimen of primary plasma cell leukemia: a case report
por: Obeidat, Mohammad Bader, et al.
Publicado: (2020)

Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma
por: Ratner, L, et al.
Publicado: (2016)

Randomized phase III trial of consolidation therapy with bortezomib–lenalidomide–Dexamethasone (VRd) vs bortezomib–dexamethasone (Vd) for patients with multiple myeloma who have completed a dexamethasone based induction regimen
por: Jacobus, S J, et al.
Publicado: (2016)

Successful treatment of non-IgM lymphoplasmacytic lymphoma by bortezomib-containing regimen: case reports and review of literature
por: Ito, Kenichi, et al.
Publicado: (2019)

Bortezomib-based Regimens Improve the Outcome of Patients with Primary or Secondary Plasma Cell Leukemia: A Retrospective Cohort Study
por: Wang, Huijuan, et al.
Publicado: (2020)

Limb gangrene: The first sign of essential thrombocythemia
por: Bolaman, Ali Zahit, et al.
Publicado: (2020)

An unusual complication of bortezomib therapy: Acute pancreatitis
por: Gupta, H., et al.
Publicado: (2014)

COVID-19-associated Evans syndrome: A case report and review of the literature
por: Turgutkaya, Atakan, et al.
Publicado: (2022)

l-asparaginase-based regimens followed by allogeneic hematopoietic stem cell transplantation improve outcomes in aggressive natural killer cell leukemia
por: Jung, Ki Sun, et al.
Publicado: (2016)

Coexistence of Acute Promyelocytic Leukemia and Primary Plasma Cell Leukemia: Careful Consideration in Diagnosis
por: Park, Joo-Heon, et al.
Publicado: (2022)

Immune modulation therapy in the management of bortezomib-induced peripheral neuropathy
por: Jeter, Ashley, et al.
Publicado: (2012)

Simultaneous Occurrence of Angioimmunoblastic T-cell Lymphoma and Plasma Cell Leukemia
por: Jang, Mi-Ae, et al.
Publicado: (2015)

Short Term Renal Outcome of Bortezomib Based Therapy in Patients with Multiple Myeloma Requiring Dialysis
por: Pandey, Alok Kumar, et al.
Publicado: (2020)

A rare case of primary plasma cell leukemia exhibiting the small-cell variant of plasma cells
por: Kim, Jung-Ah, et al.
Publicado: (2022)

Prognostic Value of Resistance Proteins in Plasma Cells from Multiple Myeloma Patients Treated with Bortezomib-Based Regimens
por: Robak, Paweł, et al.
Publicado: (2021)

Inclusion Body in a Leukocyte in Crimean-Congo Hemorrhagic Fever
por: Bolaman, Zahit, et al.
Publicado: (2015)

TRIM28 attenuates Bortezomib sensitivity of hepatocellular carcinoma cells through enhanced proteasome expression
por: Zhang, Jianchao, et al.
Publicado: (2022)

Bortezomib-induced diffuse alveolar hemorrhage in a patient with plasma cell leukemia
por: Wirth, Ingrid M., et al.
Publicado: (2020)

Effect of post-consolidation regimen on symptomatic osteonecrosis in three DCOG acute lymphoblastic leukemia protocols
por: van Atteveld, Jenneke E., et al.
Publicado: (2021)

A case of primary plasma cell leukemia exhibiting hemophagocytic plasma cells relapsed with multiple cutaneous plasmacytoma
por: Hwang, Narae, et al.
Publicado: (2017)

Fertility-Preserving Treatment Options in Patients with Malignant Hematological Diseases
por: Küçük, Mert, et al.
Publicado: (2012)

Knowledge, Attitudes, and Practices of Hematologists Regarding Fertility Preservation in Turkey
por: Küçük, Mert, et al.
Publicado: (2013)

Effect of prior treatments on selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma
por: Mateos, Maria V., et al.
Publicado: (2021)

Efficacy of bortezomib and thalidomide in the recrudescent form of multicentric mixed-type Castleman's disease
por: Lin, Q, et al.
Publicado: (2015)

Outcomes of relapsed or refractory acute myeloid leukemia after front-line hypomethylating agent and venetoclax regimens
por: Maiti, Abhishek, et al.
Publicado: (2020)

Predicting the response of multiple myeloma to the proteasome inhibitor Bortezomib by evaluation of the unfolded protein response
por: Nikesitch, N, et al.
Publicado: (2016)

Bortezomib in severe MuSK-antibody positive myasthenia gravis: first clinical experience
por: Schneider-Gold, Christiane, et al.
Publicado: (2017)

The relationship between red cell distribution width and prognostic scores in myelodysplastic syndrome
por: Turgutkaya, Atakan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ja7fo8fao7vf56afctd22vsan2